Results 21 to 30 of about 14,856,428 (285)

The impact of molecular alterations and the immune microenvironment on the natural history of Follicular Lymphoma including transformation to Diffuse Large B cell Lymphoma [PDF]

, 2009
PhDThe natural history of follicular lymphoma is heterogeneous with numerous relapses and remissions over many years. A substantial number of patients suffer an aggressive disease course with death due to disease within 5 years of diagnosis.
Lee, Abigail Mary
core   +4 more sources

Follicular variant of peripheral T-cell lymphoma

Indian Journal of Pathology and Microbiology, 2017
Globally, peripheral T-cell lymphomas (PTCLs) constitute about 12% of all non-Hodgkin lymphomas, of which the unspecified category is the most common subtype (30%).
Archana Lakshmanan, S Annapurneswari, Sheila Nair   +2 more
doaj   +1 more source

Peripheral T-cell lymphomas

Annals of Oncology, 1991
The development of T cells from stem (progenitor) cells to effector cells results from a two-wave process of proliferation and differentiation. The cells of the first differentiation wave are the precursor T cells, and those of the second differentiation wave are peripheral T cells.
H, Stein, D, Dienemann, F, Dallenbach, M, Kruschwitz   +3 more
openaire   +2 more sources

Lymphoma of the Uvula: Clinical, Morphological, Histopathological, and Genetic Characterization. A Nationwide Danish Study From 1980 to 2019

Frontiers in Surgery, 2021
Background: In the head and neck region the uvula is a rare site for extranodal lymphomas to develop. In this national study, we present six cases and provide an overview of the current literature, characterizing the clinical and histopathological ...
Lars Iversen, Lars Iversen, Patrick Rene Gerhard Eriksen, Simon Andreasen, Simon Andreasen, Erik Clasen-Linde, Preben Homøe, Irene Wessel, Christian von Buchwald, Steffen Heegaard, Steffen Heegaard   +10 more
doaj   +1 more source

Multiple osteolytic primary peripheral T-cell bone lymphoma: the first case report

Journal of International Medical Research, 2021
Peripheral T-cell lymphoma accounts for about 10% of all cases of non-Hodgkin’s lymphoma. However, less than 5% of patients with non-Hodgkin’s lymphoma present with hypercalcaemia as the initial symptom, and less than 1% present with primary bone lesions.
Chen Li, Weiguo Wang, Lingyun Xu, Dingyun Zheng, Miao Zhang, Qin Zhang, Xiaoqian Wu, Yue Yao, Wenyue Huang, Xue Li, Peipei Ying, Xiuxiu Wang, Liu Shang, Yuhu Feng   +13 more
doaj   +1 more source

Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707

Haematologica, 2017
The standard CHOP therapy for peripheral T-cell lymphoma has resulted in unsatisfactory outcomes and it is still not clear what is the optimal front-line therapy.
Yoshinobu Maeda, Hisakazu Nishimori, Isao Yoshida, Yasushi Hiramatsu, Masatoshi Uno, Yasufumi Masaki, Kazutaka Sunami, Taro Masunari, Yuichiro Nawa, Hiromichi Yamane, Hiroshi Gomyo, Tsutomu Takahashi, Tomofumi Yano, Keitaro Matsuo, Koichi Ohshima, Shigeo Nakamura, Tadashi Yoshino, Mitsune Tanimoto   +17 more
doaj   +1 more source

The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation

Haematologica, 2010
Background T follicular helper (TFH) cells reside in the light zone of germinal centers and are considered the cell of origin of angioimmunoblastic T-cell lymphoma.
Teresa Marafioti, Jennifer C. Paterson, Erica Ballabio, Andreas Chott, Yasodha Natkunam, Manuel Rodriguez-Justo, Anne Plonquet, Socorro M. Rodriguez-Pinilla, Wolfram Klapper, Martin-L. Hansmann, Stefano A. Pileri, Peter G. Isaacson, Harald Stein, Miguel A. Piris, David Y. Mason, Philippe Gaulard   +15 more
doaj   +1 more source

Therapies for Peripheral T-Cell Lymphomas [PDF]

Hematology, 2011
AbstractPeripheral T-cell lymphomas (PTCLs) are a rare and heterogeneous group of disorders that, for the most part, are associated with a very poor prognosis. The standard therapy for PTCLs is CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) or a comparable CHOP-like regimen that incorporates anthracyclines.
openaire   +2 more sources

When the mask slips: A peripheral T-cell lymphoma disguised as lupus with myelofibrosis in a patient with May-Hegglin syndrome

Leukemia Research Reports
We describe the case of a female patient with May-Hegglin syndrome who developed peripheral T-cell lymphoma not otherwise specified. The patient presents with systemic lupus erythematous phenotype and myelofibrosis secondary to T-cell lymphoma ...
V Da Silva Constante, H Couvert, A Wolfromm, M Ilzkovitz   +3 more
doaj   +1 more source

Peripheral T-cell lymphoma

Dermatology Online Journal, 2005
A 32-year-old man presented with a 5-year history of cutaneous nodules on his head and a diffuse, lichenified eruption. Histopathologic examination showed an atypical lymphocytic infiltrate. Immunophenotyping studies determined that the lymphocyte population to be CD4-positive, with partial loss of CD3 and CD7, and immunogenotyping studies showed a ...
openaire   +4 more sources